RSV in Babies: Symptoms, Treatment & Prevention Guide

Respiratory Syncytial Virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants under 1 year. Nearly all children contract it by age 2. Most cases are mild; high-risk infants can develop severe disease.

Transmission

  • Respiratory droplets (cough/sneeze), direct contact, contaminated surfaces (viable hours).
  • Incubation: 2–8 days. Contagious 3–8 days (weeks in immunocompromised).
  • Seasonal: Fall–spring peaks (varies by region).

Symptoms (Typically Appear in Stages)

  • Upper Respiratory: Runny nose, congestion, mild cough, low-grade fever, decreased appetite.
  • Lower Respiratory (Bronchiolitis): Wheezing, rapid/shallow breathing, nasal flaring, grunting, retractions (chest sinking in), cyanosis (blue lips/nails), lethargy, dehydration (fewer wet diapers).
  • Apnea: Pauses in breathing — especially in young infants/preemies.

When to Seek Immediate Care

  • Difficulty breathing (retractions, nasal flaring, grunting, >60 breaths/min)
  • Bluish lips/face
  • Inability to feed / signs of dehydration (no tears, dry mouth, <3 wet diapers/24h)
  • Fever >100.4°F (38°C) in infant <3 months
  • Extreme lethargy / difficult to arouse
  • Apnea episodes

High-Risk Infants (Need Lower Threshold for Care)

  • Premature (<35 weeks gestation)
  • <6 months chronological age
  • Chronic lung disease (BPD)
  • Congenital heart disease (hemodynamically significant)
  • Neuromuscular disorders, immunodeficiency

Treatment (Supportive — No Routine Antiviral)

  • Hydration: Frequent small feeds. IV fluids if unable to maintain orally.
  • Nasal Suctioning: Saline drops + bulb syringe/aspirator before feeds/sleep.
  • Fever/Pain: Acetaminophen (≥2 mos) or ibuprofen (≥6 mos) per weight dosing.
  • Oxygen: For hypoxia (SpO₂ <90–92%).
  • Hospitalization Indications: Respiratory distress, hypoxia, apnea, dehydration, high-risk infant.
  • NOT Routinely Used: Albuterol (no consistent benefit), steroids, antibiotics (unless bacterial co-infection), chest physiotherapy.

Prevention

For All Infants

  • Hand hygiene (soap/water 20 sec or sanitizer).
  • Limit exposure to sick people; avoid crowds in peak season.
  • No smoking/vaping exposure.
  • Breastfeeding (antibodies in milk).
  • Surface disinfection.

For High-Risk Infants: Palivizumab (Synagis)

  • Monoclonal antibody. Monthly IM injections during RSV season (typically 5 doses).
  • Indications: <29 wks GA; <32 wks GA + CLD; hemodynamically significant CHD; others per AAP guidelines.
  • Reduces hospitalization ~50%. Does not prevent infection.

New: Maternal RSV Vaccine (Abrysvo)

  • Given 32–36 weeks gestation (Sept–Jan in US). Transfers antibodies to fetus.
  • Reduces severe RSV in infants <6 months by ~80%.

New: Nirsevimab (Beyfortus)

  • Long-acting monoclonal antibody. Single dose at birth or start of season.
  • For all infants <8 months entering first RSV season; high-risk 8–19 months entering second season.
  • >75% efficacy against medically attended RSV.

RSV is common and usually mild. Vigilance for breathing difficulty and dehydration—especially in high-risk babies—ensures timely intervention.

Baby Health - Related Articles